Gainey McKenna & Egleston announce a class action lawsuit
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action has been filed on behalf of investors
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action has been filed on behalf of investors
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been
LAVAL, Quebec, Sept. Oct. 30, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ:ACAST) announced full year 2013-2014 results. (“Acasti” or the “Company”) ACSTACSTa specialty late-stage
LAVAL, Quebec, Sept. 30, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage specialty pharmaceutical company
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been commenced on
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on
US District Judge Ann Donnelly has ordered several assets frozen related to individuals and entities accused of operating a US supply chain that distributes counterfeit
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (“Centessa” or
SOUTH SAN FRANCISCO, Calif., September 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. ALGSA clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action has been filed on behalf of investors
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been
LAVAL, Quebec, Sept. Oct. 30, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ:ACAST) announced full year 2013-2014 results. (“Acasti” or the “Company”) ACSTACSTa specialty late-stage
LAVAL, Quebec, Sept. 30, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage specialty pharmaceutical company
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been commenced on
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on
US District Judge Ann Donnelly has ordered several assets frozen related to individuals and entities accused of operating a US supply chain that distributes counterfeit
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (“Centessa” or
SOUTH SAN FRANCISCO, Calif., September 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. ALGSA clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to